Proprio announced the U.S. Food and Drug Administration (FDA) has granted clearance for the “Picasso” feature. This marks the company’s fourth FDA-cleared capability within its Paradigm platform.
The Paradigm AI platform provides continuous, three-dimensional measurements that allow surgeons to assess spinal alignment intraoperatively. Growing clinical research has underscored the limitations of traditional two-dimensional assessment and the value of richer 3D characterization in understanding spinal anatomy and alignment.
The Picasso clearance expands Paradigm’s surgeon-controlled registration workflow, enabling trace-based optical registration within the Paradigm system to support intraoperative spinal alignment measurement across a broader range of spine procedures.
Picasso is designed for surgeons seeking alternatives to radiation-dependent navigation workflows and technician-led registration processes. The radiation-free, trace-based approach allows surgeons to verify and refine registration optically, without requiring CBCT spins or restarting the workflow.
“Historically, spine surgeons have had limited ways to verify alignment during a procedure itself,” said Gabriel Jones, CEO and Co-Founder of Proprio. “As intraoperative measurement becomes more practical, surgeons are looking for tools that let them assess progress while they are operating, not after the fact. Picasso extends Paradigm’s existing 3D guidance capabilities by giving surgeons more direct control over registration at the point of care.”
Proprio announced the U.S. Food and Drug Administration (FDA) has granted clearance for the "Picasso" feature. This marks the company's fourth FDA-cleared capability within its Paradigm platform.
The Paradigm AI platform provides continuous, three-dimensional measurements that allow surgeons to assess spinal alignment intraoperatively....
Proprio announced the U.S. Food and Drug Administration (FDA) has granted clearance for the “Picasso” feature. This marks the company’s fourth FDA-cleared capability within its Paradigm platform.
The Paradigm AI platform provides continuous, three-dimensional measurements that allow surgeons to assess spinal alignment intraoperatively. Growing clinical research has underscored the limitations of traditional two-dimensional assessment and the value of richer 3D characterization in understanding spinal anatomy and alignment.
The Picasso clearance expands Paradigm’s surgeon-controlled registration workflow, enabling trace-based optical registration within the Paradigm system to support intraoperative spinal alignment measurement across a broader range of spine procedures.
Picasso is designed for surgeons seeking alternatives to radiation-dependent navigation workflows and technician-led registration processes. The radiation-free, trace-based approach allows surgeons to verify and refine registration optically, without requiring CBCT spins or restarting the workflow.
“Historically, spine surgeons have had limited ways to verify alignment during a procedure itself,” said Gabriel Jones, CEO and Co-Founder of Proprio. “As intraoperative measurement becomes more practical, surgeons are looking for tools that let them assess progress while they are operating, not after the fact. Picasso extends Paradigm’s existing 3D guidance capabilities by giving surgeons more direct control over registration at the point of care.”
Copy to clipboard 
